Novanta (FRA:1GSN) FFO


FRA:1GSN Novanta Inc FRA:1GSN
87 GF Score
Price €140.00
GF Value €136.44
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Novanta FFO?

FFO (Funds from operations) only applies to REITs.

FRA:1GSN
87GF Score
Novanta Inc FRA:1GSN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Novanta (FRA:1GSN) Overvalued in 2026?

Based on GuruFocus' analysis, Novanta stock appears to be overvalued. The current stock price of €140.00 is trading 2.6% above its estimated GF Value™ of €136.44. GuruFocus considers Novanta to be Fairly Valued.

Key valuation signals for FRA:1GSN:

  • FFO:
  • GF Value™: €136.44 vs. price of €140.00 (2.6% above fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the FRA:1GSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novanta Business Description

Address 125 Middlesex Turnpike, Bedford, MA, USA, 01730
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.
87GF Score

Get the complete analysis for FRA:1GSN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€140.00
Price
€136.44
GF Value